BTSMX
Price
$24.99
Change
-$0.01 (-0.04%)
Updated
Nov 12 closing price
Net Assets
747.74M
FSMAX
Price
$101.36
Change
-$0.06 (-0.06%)
Updated
Nov 12 closing price
Net Assets
41.46B
Interact to see
Advertisement

BTSMX vs FSMAX

Header iconBTSMX vs FSMAX Comparison
Open Charts BTSMX vs FSMAXBanner chart's image
Boston Trust SMID Cap
Price$24.99
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets747.74M
Fidelity Extended Market Index
Price$101.36
Change-$0.06 (-0.06%)
VolumeN/A
Net Assets41.46B
BTSMX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
BTSMX vs. FSMAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTSMX is a Buy and FSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.5B vs. BTSMX (748M). BTSMX pays higher dividends than FSMAX: BTSMX (0.85) vs FSMAX (0.43). BTSMX was incepted earlier than FSMAX: BTSMX (14 years) vs FSMAX (14 years). BTSMX (0.82) is less costly to investors than FSMAX (0.04). BTSMX is a more actively managed with annual turnover of: 31.51 vs. FSMAX (15.00). FSMAX has a lower initial minimum investment than BTSMX: FSMAX (0) vs BTSMX (1000000). FSMAX annual gain was more profitable for investors over the last year : 6.78 vs. BTSMX (-5.95). FSMAX return over 5 years is better than : 44.78 vs. BTSMX (42.14).
BTSMXFSMAXBTSMX / FSMAX
Total Expense Ratio0.750.042,143%
Annual Report Gross Expense Ratio0.820.042,343%
Fund Existence14 years14 years-
Gain YTD0.36111.5983%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets748M41.5B2%
Annual Yield % from dividends0.850.43198%
Returns for 1 year-5.956.78-88%
Returns for 3 years17.2953.3032%
Returns for 5 years42.1444.7894%
Returns for 10 years108.71108.36100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTH38.722.62
+7.26%
Dianthus Therapeutics
SAR22.370.35
+1.59%
SARATOGA INVESTMENT Corp
FBIOP6.800.10
+1.49%
Fortress Biotech
GOCO3.440.02
+0.58%
GoHealth
DOX77.36-6.60
-7.86%
Amdocs Limited